Drug
Pimozide clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 2004 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 8
University of Calgary (2) · Food and Drug Administration (FDA) (1) · Technical University of Munich (1) · Yale University (1) · Icahn School of Medicine at Mount Sinai (1) · National Center for Research Resources (NCRR) (1) · Hannover Medical School (1) · Applied Biology, Inc. (1)
Often tested with
Tested in the same studies.
Olanzapine (2) · Amisulpride (2) · Risperidone (2) · Haloperidol (2) · Quetiapine (2) · Perphenazine (2) · Sulpiride (2) · Bromperidol (2)
Studies
Open first, then newest update. How each study uses Pimozide is read from its arms, and is right about nine times in ten.
Testing it · 9
- Electrophysiological Effects of Potential QT Prolonging DrugsCompletedPhase 1Food and Drug Administration (FDA)NCT05716854Written as Pimozide
- Treatment for Post Acute COVID-19 SyndromeStatus unknownNot applicableApplied Biology, Inc.NCT05507372Written as Pimozide 1 MG
- A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownPhase 2University of CalgaryNCT03272503Written as Pimozide 2mg/day (current) or 4 mg/day (study initiation)
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedPhase 4Technical University of MunichNCT02307396Written as Pimozide
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Pimozide
- A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALSStatus unknownPhase 2University of CalgaryNCT02463825Written as Pimozide 2 mg per day
- Efficacy of Pimozide Augmentation for Clozapine Partial ResponseCompletedPhase 2Yale UniversityNCT00374244Written as Pimozide
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of SchizophreniaCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT00158223Written as Pimozide
- Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette SyndromeCompletedPhase 2National Center for Research Resources (NCRR)NCT00004652Written as pimozide
As the comparator · 1 — what is tested is compared with Pimozide
Codes
What other systems call Pimozide · ClinicalTrials.gg INT008023
- MeSH (NLM) D010868PimozideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1HIZ4DL86FPIMOZIDEConfirmed FDA, NLM, Wikidata
- RxNorm 8331Confirmed FDA, Wikidata
- Wikidata Q144085pimozideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47672PimozideOne source FDA
- DrugBank DB01100One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010868 | Pimozide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1HIZ4DL86F | PIMOZIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8331 | — | Confirmed FDA, Wikidata |
| Wikidata | Q144085 | pimozide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47672 | Pimozide | One source FDA |
| DrugBank | DB01100 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.